Chengdu Easton Biopharmaceuticals (688513.SHG) Q3 2024 Earnings

19AugConfirmed
Q1 2023
Q2 2023
Q2 2024
Q3 2024
0.43
0.48
0.53
0.59

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Chengdu Easton Biopharmaceuticals (688513.SHG) will report earnings of for Q3 2024 on August 19, 2024.

0 Comments

Share your thoughts